Argenx
ARGX
#421
Rank
HK$457.21 B
Marketcap
HK$7,271
Share price
3.63%
Change (1 day)
7.48%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

EPS for Argenx (ARGX)

EPS in 2023 (TTM): -HK$32.58

According to Argenx 's latest financial reports the company's current EPS (TTM) is HK$175.33. In 2022 the company made an earnings per share (EPS) of -HK$102.88.

EPS history for Argenx from 2022 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$32.58-68.33%
2022-HK$102.88